D Maraninchi

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Michel Marty, Francesco Cognetti, D Maraninchi et al. · IRIS UNIMORE (University of Modena and Reggio Emilia) · 2005 · 1.6K citations · Full text

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Thierry Philip, Jamés O. Armitage, Gary Spitzer et al. · New England Journal of Medicine · 1987 · 780 citations

Cell Therapy, Refractory Group, Pathology +18

IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS

D Maraninchi, Didier Blaise, Bernard Rio et al. · The Lancet · 1987 · 306 citations

Cell Therapy, Transplantation, Marrow Transplantation +10

Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers

François Bertucci, Pascal Finetti, Nathalie Cervera et al. · Cancer Research · 2006 · 292 citations · Full text

Breast Oncology, Engineering, Genetics +16

Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging

NC Gorin, Philippe Aegerter, B Auvert et al. · Blood · 1990 · 279 citations